Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03007979
Title Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

Her2-receptor negative breast cancer

Therapies

Goserelin

Fulvestrant + Palbociclib

Letrozole + Palbociclib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST